A Novel Isotope-labeled Small Molecule Probe CC12 for Anti-glioma via Suppressing LYN-mediated Progression and Activating Apoptosis Pathways
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas | Communications Biology
CCL2-Expressing Astrocytes Mediate the Extravasation of T Lymphocytes in the Brain. Evidence from Patients with Glioma and Experimental Models In Vivo | PLOS ONE
Frontiers | Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner
Immune cell trafficking across the blood-brain barrier in the absence and presence of neuroinflammation in: Vascular Biology Volume 2 Issue 1 (2020)
Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke | American Journal of Physiology-Cell Physiology
CCL2-Expressing Astrocytes Mediate the Extravasation of T Lymphocytes in the Brain. Evidence from Patients with Glioma and Experimental Models In Vivo | PLOS ONE
Frontiers | Deciphering immune microenvironment and cell evasion mechanisms in human gliomas
Glioma-derived exosomes hijack the blood–brain barrier to facilitate nanocapsule delivery via LCN2 - ScienceDirect
Crosstalk among BC cells, glial cells, and the brain microenvironment.... | Download Scientific Diagram
Pharmaceutics | Free Full-Text | Neuroimmunomodulatory Properties of Flavonoids and Derivates: A Potential Action as Adjuvants for the Treatment of Glioblastoma
IJMS | Free Full-Text | Microglia and the Blood–Brain Barrier: An External Player in Acute and Chronic Neuroinflammatory Conditions
Remodeling the blood–brain barrier microenvironment by natural products for brain tumor therapy - ScienceDirect
IJMS | Free Full-Text | Microglia and the Blood–Brain Barrier: An External Player in Acute and Chronic Neuroinflammatory Conditions
The CCL2-CCR2 astrocyte-cancer cell axis in tumor extravasation at the brain | Science Advances
Frontiers | Origin, activation, and targeted therapy of glioma-associated macrophages
CCL2 (C-C Motif Chemokine Ligand 2) Biomarker Responses in Central Versus Peripheral Compartments After Focal Cerebral Ischemia | Stroke
Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI | Scientific Reports
Frontiers | Study of BBB Dysregulation in Neuropathogenicity Using Integrative Human Model of Blood–Brain Barrier
Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI | Scientific Reports
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas | Communications Biology
Frontiers | Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
Smart Nanomedicine to Enable Crossing Blood–Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma | ACS Nano
Frontiers | CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy
The blood–tumour barrier in cancer biology and therapy | Nature Reviews Clinical Oncology
